Affiliation:
1. Kyrgyz State Medical Academy named after I.K. Akhunbaev;
Kyrgyz-Russian Slavic University named after the First President of the Russian Federation B.N. Yeltsin
2. Scientific and Research Institute of Molecular Biology and Medicine
3. I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenov University),
4. Osh State University
5. Kyrgyz State Medical Academy named after I.K. Akhunbaev
Abstract
The aim of the study was to summarize the literature data on various types of systemic vasculitis, their mechanisms of development, diagnostic possibilities, and to describe a clinical case. Systemic vasculitis is a group of diseases with heterogeneous etiology, which involve vessels of different calibers, predominantly small and/or medium, manifesting as multi-organ dysfunction, difficult to treat, and with a poor prognosis. Currently, the following types are distinguished: large vessel vasculitis; medium vessel vasculitis; small vessel vasculitis; variable vessel vasculitis; single-organ vasculitis; vasculitis associated with systemic diseases; vasculitis associated with specific etiology. In the clinic of internal medicine, kidney involvement (glomeruloand tubulopathies, renal insufficiency), skin (ulcerative-necrotic and trophic changes), lungs (interstitial involvement, respiratory insufficiency, recurrent pneumonias), and central nervous system (acute ischemic events, thromboses, polyneuropathies, cognitive disorders, gait disturbances), heart (myocarditis with heart failure) are most commonly encountered. Systemic vasculitis most often manifests in winter and spring periods. Hemorrhagic vasculitis and Kawasaki disease are most commonly seen among children and young adults. In the post-COVID era, systemic vasculitis has been detected more frequently. The study presents the results of personal observation of a patient suffering from infectious-toxic systemic vasculitis.
Publisher
Medical Informational Agency Publishers
Reference46 articles.
1. Beketova T.V., Nasonov E.L. Current trends in classification and treatment of systemic vasculitis associated with anti-neutrophilic cytoplasmic antibodies: results of 2011. Terapevticheskii arkhiv.2012;84:5:68–74. (In Russian).
2. Mukhin N.A., Novikov P.I., Moiseev S.V., Semenkova E.N., Kozlovskaya L.V., Fomin V.V., Lopatina I.A. Eff ektivnost’ i bezopasnost’ genno-inzhenernykh biologicheskikh preparatov u patsientov s revmatoidnym artritom i drugimi revmaticheskimi zabolevaniyami (prospektivnoe nekontroliruemoe issledovanie). Klinicheskaya farmakologiya i terapiya. 2012;21(5):25–32. (In Russian).
3. Guseva N.G., Nasonova Y.A., Ivanova M.M. Academician Eugeny Mihailovich Tareev and significance of his ideas in modem rheumatology. Rheumatology Science and Practice. 2008;46(6):86– 91. (In Russian). DOI: 10.14412/1995-4484-2008-496
4. Chuchalin A.G. Primary systemic and pulmonary vasculitis. RMJ. 2001;21:912. (In Russian).
5. Beketova T.V., Golovina O.A., Avdeeva A.S. Cli ni cal and immunological variants of ANCA-associated systemic vas culitis: a look at the pulmonary fibrosis in microscopic polyangiitis with antimyeloperoxidase antibodies and rheumatoid factor. Litera ture review and own observation. Rheumatology Science and Practice. 2023; 61(1):62–69. (In Russian). DOI: 10.47360/1995-4484-2023-62-69
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献